-- Swiss Stocks Rebound From Two-Week Low as Novartis Gains
-- B y   C o r i n n e   G r e t l e r
-- 2013-11-05T08:32:54Z
-- http://www.bloomberg.com/news/2013-11-05/swiss-stocks-rebound-from-two-week-low-as-novartis-gains.html
Stocks in Switzerland  rose, with the
Swiss Market Index rebounding from a two-week low, as  Novartis
AG (NOVN)  shares climbed after people familiar with the matter said the
company is exploring the sale of its animal-health business.  Novartis, Europe’s biggest drugmaker, added 1.2 percent,
contributing the most to the benchmark gauge’s advance.  Syngenta
AG (SYNN)  and  Givaudan SA (GIVN)  followed a gauge of the region’s chemical
companies higher.  Credit Suisse Group AG (CSGN)  fell 1.9 percent.  The SMI increased 0.2 percent to 8,202.91 at 9:30 a.m. in
Zurich. The gauge rallied 2.6 percent in October as U.S.
lawmakers agreed on a new budget to avoid a sovereign default
and to end a partial government shutdown. The broader Swiss
Performance Index also gained 0.2 percent today.  The volume of shares changing hands in companies listed on
the  SMI (SMI)  was more than double the average of the past 30 days,
data compiled by Bloomberg show.  Novartis climbed 1.2 percent to 70.95 Swiss francs. The
company has identified its animal-health business for a sale as
part of Chairman Joerg Reinhardt’s revamp plan, according to
three people familiar with the matter. The drugmaker is working
with Goldman Sachs Group Inc. on a portfolio review and is also
considering selling its over-the-counter medicines unit and its
vaccines operation, according to the people.  To contact the reporter on this story:
Corinne Gretler in Zurich at 
 cgretler1@bloomberg.net   To contact the editor responsible for this story:
Andrew Rummer at 
 arummer@bloomberg.net  